会員登録
ログイン
【4599】ステムリム
再生医薬品の研究開発
類似企業：
【業界1位】
協和キリン
【業界1位】
協和キリン
| 保有者 | 2019.7 | 2020.1 | 2020.7 | 2021.1 | 2021.7 | 2022.1 | 2022.7 | 2023.1 | 2023.7 | 2024.1 | 2024.7 | 2025.1 | 2025.7 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 玉井 克人 | 9,600,000 (21.7%) |
9,600,000
(18.1%)
|
9,600,000
(16.9%)
|
9,600,000
(16.44%)
|
9,600,000
(16.31%)
|
9,600,000
(16.19%)
|
9,600,000
(16.16%)
|
9,600,000
(16.0%)
|
9,600,000
(15.8%)
|
9,702,000
(15.78%)
|
9,702,000
(15.8%)
|
9,852,000
(15.9%)
|
9,852,000
(15.9%)
|
| 玉井 佳子 | 5,400,000 (12.2%) |
5,400,000
(10.2%)
|
5,400,000
(9.51%)
|
5,400,000
(9.25%)
|
5,400,000
(9.18%)
|
5,400,000
(9.1%)
|
5,400,000
(9.09%)
|
5,400,000
(9.0%)
|
5,400,000
(8.9%)
|
5,400,000
(8.78%)
|
5,400,000
(8.8%)
|
5,400,000
(8.7%)
|
5,400,000
(8.7%)
|
| 冨田 憲介 | 3,450,000 (7.8%) |
3,600,000
(6.8%)
|
4,342,000
(7.65%)
|
5,017,000
(8.59%)
|
5,017,000
(8.52%)
|
5,038,000
(8.49%)
|
5,038,000
(8.48%)
|
5,167,000
(8.61%)
|
3,896,000
(6.4%)
|
5,015,000
(8.16%)
|
5,015,000
(8.2%)
|
5,015,000
(8.1%)
|
5,014,000
(8.1%)
|
| 塩野義製薬株式会社 | 1,800,000 (3.17%) |
1,800,000
(3.08%)
|
1,800,000
(3.06%)
|
1,800,000
(3.03%)
|
1,800,000
(3.03%)
|
1,800,000
(3.0%)
|
1,800,000
(3.0%)
|
1,800,000
(2.93%)
|
1,800,000
(2.9%)
|
4,650,000
(7.5%)
|
4,650,000
(7.5%)
|
||
| 五味 大輔 | 1,965,000 (3.31%) |
2,590,000
(4.32%)
|
2,910,000
(4.8%)
|
2,850,000
(4.64%)
|
3,260,000
(5.3%)
|
3,430,000
(5.5%)
|
3,535,000
(5.7%)
|
||||||
| 山﨑 尊彦 | 1,380,000 (3.1%) |
2,030,000
(3.57%)
|
2,030,000
(3.48%)
|
2,450,000
(4.16%)
|
2,450,000
(4.13%)
|
2,450,000
(4.12%)
|
2,450,000
(4.08%)
|
2,450,000
(4.0%)
|
2,450,000
(3.99%)
|
2,450,000
(4.0%)
|
2,410,000
(3.9%)
|
2,410,000
(3.9%)
|
|
| みやこ京大イノベーション投資事業有限責任組合 | 2,443,000 (5.5%) |
2,443,000
(4.6%)
|
2,443,000
(4.3%)
|
2,443,000
(4.19%)
|
2,443,000
(4.15%)
|
2,443,000
(4.12%)
|
2,443,000
(4.11%)
|
2,443,000
(4.07%)
|
2,443,000
(4.0%)
|
1,943,000
(3.16%)
|
1,943,000
(3.2%)
|
1,943,000
(3.1%)
|
1,943,000
(3.1%)
|
| 金崎 努 | 1,150,000 (2.1%) |
1,600,000
(2.82%)
|
2,065,000
(3.54%)
|
2,065,000
(3.51%)
|
2,065,000
(3.48%)
|
2,065,000
(3.48%)
|
2,004,000
(3.34%)
|
1,844,000
(3.0%)
|
1,844,000
(3.0%)
|
1,844,000
(3.0%)
|
1,811,000
(2.9%)
|
1,724,000
(2.8%)
|
|
| 岡島 正恒 | 721,000 (1.2%) |
721,000
(1.2%)
|
|||||||||||
| 有限会社イー・シー・エス | 717,000 (1.2%) | ||||||||||||
| 公益財団法人加藤記念バイオサイエンス振興財団 | 900,000 (1.5%) |
900,000
(1.4%)
|
|||||||||||
| 株式会社SMBC信託銀行信託口08900027 | 2,850,000 (4.8%) |
2,850,000
(4.75%)
|
2,850,000
(4.7%)
|
2,850,000
(4.64%)
|
2,850,000
(4.6%)
|
||||||||
| 大久保 俊幸 | 4,650,000 (10.5%) |
4,650,000
(8.7%)
|
4,382,000
(7.72%)
|
3,626,000
(6.21%)
|
2,788,000
(4.74%)
|
2,379,000
(4.01%)
|
1,789,000
(3.01%)
|
1,475,000
(2.46%)
|
917,000
(1.49%)
|
||||
| 株式会社SBI証券 | 1,157,000 (1.95%) |
1,593,000
(2.6%)
|
|||||||||||
| 特定有価証券信託受託者株式会社SMBC信託銀行信託口08900027 | 2,850,000 (6.4%) |
2,850,000
(5.4%)
|
2,850,000
(5.02%)
|
2,850,000
(4.88%)
|
2,850,000
(4.84%)
|
2,850,000
(4.81%)
|
|||||||
| 大和日台バイオベンチャー投資事業有限責任組合 | 2,333,000 (5.3%) |
2,333,000
(4.4%)
|
1,000,000
(1.76%)
|
1,000,000
(1.71%)
|
1,000,000
(1.7%)
|
||||||||
| 大阪バイオファンド投資事業有限責任組合 | 2,433,000 (5.5%) |
2,433,000
(4.6%)
|
|||||||||||
| 臼井 玲 | 1,320,000 (3.0%) |
1,320,000
(2.5%)
|
